The two-year plan presents various measures to prevent, treat and control extensively drug-resistance tuberculosis (XDRT-TB) and multi drug-resistance tuberculosis (MDR-TB).
In addition, the plan has started a series of actions to reach one of the 2015 Millennium Development Goals, which is focused on the access to drugs and diagnostic TB tests.
Concretely, the plan centres on investment in key areas such as:
strengthening programmes to treat drug-resistant TB
building capacity in diagnostic laboratories
expanding infection control and surveillance
funding research into new and improved diagnostics, drugs and vaccines
The total budget for the two-year plan is US$ 2.15 billion, of which 80% is for country-specific needs. Also, its activities will be carried out in all six WHO regions.
For more information about Tuberculosis:
WHO article about TB plan
Second Global Plan brings the fight against TB to a new level
Drug resistant TB : a growing problem for Europe
WHO: Frequently asked questions - XDR-TB
TB alliance to sponsor drug study
World TB Day 2006: a mixed picture
